FDA label
What is albuterol used for?
The FDA-approved uses of albuterol, quoted from the Indications and Usage section of its DailyMed label.
Source: DailyMed SPL label file dated 2026-10-23. Publisher page
The FDA label says: “Albuterol Inhalation Solution is indicated for the relief of bronchospasm in patients 2 to 12 years of age with asthma (reversible obstructive airway disease).”
Run it in Rivvi
Which 2027 plans near you dropped or restricted albuterol?
Tier changes and new prior auth, step therapy or quantity limits, plan by plan.
Free to start. Opens Rivvi, the AI workspace for healthcare teams.
Albuterol Sulfate, solution
Indications and Usage, quoted from the label by Ritedose Pharmaceuticals, LLC (ANDA214531). Cross-references to other label sections are left out.
Albuterol Inhalation Solution is indicated for the relief of bronchospasm in patients 2 to 12 years of age with asthma (reversible obstructive airway disease).
Source: DailyMed label, set id d4c532be-1f41-60d3-e053-2995a90a98be, version 10, effective April 30, 2026. NDC 76204-010, one of 49 listings for this product.
Albuterol Sulfate, aerosol, metered
Indications and Usage, quoted from the label by Sportpharm LLC (ANDA207085). Cross-references to other label sections are left out.
Albuterol sulfate inhalation aerosol is indicated in adults and children 4 years of age and older for the treatment or prevention of bronchospasm with reversible obstructive airway disease and for the prevention of exercise-induced bronchospasm.
Source: DailyMed label, set id e31d8d13-ac19-4738-97d4-d7790ce2e8e3, version 4, effective April 24, 2026. NDC 85766-020, one of 21 listings for this product.
Albuterol Sulfate, tablet
Indications and Usage, quoted from the label by Sun Pharmaceutical Industries, Inc. (ANDA072637). Cross-references to other label sections are left out.
Albuterol tablets are indicated for the relief of bronchospasm in adults and children 6 years of age and older with reversible obstructive airway disease.
Source: DailyMed label, set id 87b8cd3c-2849-4b50-b63e-9ea379165c07, version 7, effective March 16, 2026. NDC 53489-176, one of 20 listings for this product.
Questions
What is albuterol used for?
The FDA label says: “Albuterol Inhalation Solution is indicated for the relief of bronchospasm in patients 2 to 12 years of age with asthma (reversible obstructive airway disease).”
What drug class is albuterol?
FDA lists albuterol in the beta2-Adrenergic Agonist established pharmacologic class.
Does this page cover off-label uses or dosing?
No. This page shows only the Indications and Usage section of the FDA label. Ask a pharmacist or prescriber about dosing.
More on Albuterol
- Is Albuterol a controlled substance?Federal schedule
- Generic for Proair HFAFDA Orange Book
- Generic for ProventilFDA Orange Book
- Generic for Proventil-hfaFDA Orange Book
- Generic for VentolinFDA Orange Book
- Generic for Ventolin HFAFDA Orange Book
- Generic for ProAir RespiClickFDA Orange Book
- Generic for AccunebFDA Orange Book
- What is Ventolin HFA used for?FDA label uses
- Is Ventolin HFA a controlled substance?Federal schedule
- What is ProAir RespiClick used for?FDA label uses
- Is ProAir RespiClick a controlled substance?Federal schedule
- Beta2-Adrenergic Agonists listFDA drug class
- Albuterol Medicare Part D coverageBy plan and state
- NDC 0173-0682Albuterol NDC record
- NDC 50090-1158Albuterol NDC record